Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TENX — Tenax Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,207,336
+$3,743,994 QoQ
Shares Held
289,164
+897.9% QoQ
Ownership
0.773%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 111 holders
Holding Since
Dec 2023
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TENX Over Time

Shares Held

Position Value (USD)

Derivatives in TENX

reported options exposure · as of Jun 30, 2026
CallValue
$1,408,440
CallShares
96,800
PutValue
$3,422,160
PutShares
235,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. TENX ranks #57 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in TENX

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,422,160 235,200
2026-06-30 $4,207,336 289,164
2026-06-30 $1,408,440 96,800
2026-03-31 $463,342 28,977
2023-12-31 $20,947 76,171